Brookfield Asset Management Inc. Dexcom Inc Transaction History

Brookfield Asset Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	BUY	$112.47 - $130.98 $4.71 Million - $5.49 Million	41,897 Added 38.31%	151,252 $19.4 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $4.71 Million - $5.49 Million	41,897 Added 38.31%	151,252 $19.4 Million
Q1 2023 Sep 25, 2023	SELL	$104.0 - $122.92 $4.36 Million - $5.15 Million	-41,897 Reduced 27.7%	109,355 $12.7 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $3.82 Million - $4.51 Million	-36,691 Reduced 25.12%	109,355 $12.7 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $4.58 Million - $6.61 Million	53,866 Added 58.44%	146,046 $16.5 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $7.04 Million - $8.68 Million	92,180 New	92,180 $7.42 Million

1,021

352M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.